Table 2.
Medication ranking by Medicare claim volume | Generic drug name | Estimated Medicare savings at MCCPDC 30C pricing (2023 USD) | Percent savings w MCCPDC 30C | Estimated Medicare savings at MCCPDC 90C pricing (2023 USD) | Percent savings w MCCPDC 90C |
---|---|---|---|---|---|
3 | Prednisone | −$2 201 502 | −120% | $60 166 | 3% |
5 | Dexamethasone | −$3 908 678 | −81% | −$1 641 523 | −34% |
6 | Ondansetron HCl | $1 199 494 | 25% | $2 875 840 | 61% |
22 | Ondansetron ODT | $738 762 | 36% | $1 253 439 | 61% |
25 | Pantoprazole sodium | −$611 741 | −48% | $451 619 | 35% |
28 | Omeprazole | −$818 073 | −89% | $159 119 | 17% |
50 | Venlafaxine HCl | −$56 619 | −9% | $352 606 | 57% |
51 | Mirtazapine | $107 098 | 23% | $311 160 | 66% |
52 | Famotidine | −$343 723 | −119% | $35 733 | 12% |
53 | Duloxetine HCl | $82 127 | 12% | $401 842 | 58% |
54 | Promethazine HCl | −$235 248 | −83% | $74 966 | 27% |
75 | Methylprednisolone | −$10 504 | −8% | $42 718 | 33% |
82 | Loperamide HCl | −$100 218 | −40% | $56 307 | 23% |
107 | Metoclopramide HCl | −$164 101 | −303% | −$37 587 | −69% |
114 | Meloxicam | −$59 787 | −166% | −$2331 | −6% |
117 | Cyclobenzaprine HCl | −$24 426 | −30% | $38 838 | 48% |
120 | Deferasirox | $21 758 071 | 98% | $21 831 575 | 98% |
123 | Ibuprofen | −$57 749 | −122% | $5336 | 11% |
124 | Celecoxib | $71 995 | 40% | $131 603 | 74% |
144 | Hydroxyzine HCl | −$57 525 | −131% | −$7038 | −16% |
150 | Esomeprazole Mg | $129 053 | 63% | $166 463 | 81% |
154 | Aprepitant | $388 500 | 30% | $391 542 | 30% |
166 | Baclofen | −$24 775 | −49% | $18 714 | 37% |
177 | Quetiapine fumarate | $575 | 1% | $21 624 | 48% |
209 | Granisetron HCl | $56 762 | 52% | $65 258 | 60% |
219 | Naproxen | −$16 979 | −123% | −$213 | −2% |